Macular telangiectasia (MacTel) is an eye disease that affects the macula. In MacTel, the tiny blood vessels around the fovea (the very center of the macula) become abnormal. They may widen ...

The FDA approved revakinagene taroretcel (Encelto) as the first treatment for adults with idiopathic macular telangiectasia ... human CNTF -- to the affected eye via a surgical intravitreal ...

Neurotech Pharma's cell therapy Encelto has become the first FDA-approved treatment for idiopathic macular telangiectasia type 2 (MacTel), a rare eye disease leading to progressive and ...